Cargando…

A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge

BACKGROUND: Marburg virus (MARV), an Ebola-like virus, remains an eminent threat to public health as demonstrated by its high associated mortality rate (23–90%) and recent emergence in West Africa for the first time. Although a recombinant vesicular stomatitis virus (rVSV)-based vaccine (Ervebo) is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Woolsey, Courtney, Cross, Robert W., Agans, Krystle N., Borisevich, Viktoriya, Deer, Daniel J., Geisbert, Joan B., Gerardi, Cheryl, Latham, Theresa E., Fenton, Karla A., Egan, Michael A., Eldridge, John H., Geisbert, Thomas W., Matassov, Demetrius
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9182267/ https://www.ncbi.nlm.nih.gov/pubmed/35622847 http://dx.doi.org/10.1371/journal.pntd.0010433

Ejemplares similares

Postexposure Efficacy of Recombinant Vesicular Stomatitis Virus Vectors Against High and Low Doses of Marburg Virus Variant Angola in Nonhuman Primates
por: Woolsey, Courtney, et al.
Publicado: (2018)

Immune correlates of postexposure vaccine protection against Marburg virus
por: Woolsey, Courtney, et al.
Publicado: (2020)

Single dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus
por: Mire, Chad E., et al.
Publicado: (2015)

A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease
por: Foster, Stephanie L., et al.
Publicado: (2022)

Use of convalescent serum reduces severity of COVID-19 in nonhuman primates
por: Cross, Robert W., et al.
Publicado: (2021)

Natural history of nonhuman primates after conjunctival exposure to Ebola virus
por: Cross, Robert W., et al.
Publicado: (2023)

Marburg and Ravn Viruses Fail to Cause Disease in the Domestic Ferret (Mustela putorius furo)
por: Cross, Robert W, et al.
Publicado: (2018)

Oral and Conjunctival Exposure of Nonhuman Primates to Low Doses of Ebola Makona Virus
por: Mire, Chad E., et al.
Publicado: (2016)

Durability of a Vesicular Stomatitis Virus-Based Marburg Virus Vaccine in Nonhuman Primates
por: Mire, Chad E., et al.
Publicado: (2014)

Use of Single-Injection Recombinant Vesicular Stomatitis Virus Vaccine to Protect Nonhuman Primates Against Lethal Nipah Virus Disease
por: Mire, Chad E., et al.
Publicado: (2019)

Bundibugyo ebolavirus Survival Is Associated with Early Activation of Adaptive Immunity and Reduced Myeloid-Derived Suppressor Cell Signaling
por: Woolsey, Courtney, et al.
Publicado: (2021)

A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virus
por: Cross, Robert W., et al.
Publicado: (2023)

An Intranasal Exposure Model of Lethal Nipah Virus Infection in African Green Monkeys
por: Geisbert, Joan B, et al.
Publicado: (2020)

Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase
por: Cross, Robert W, et al.
Publicado: (2020)

Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase
por: Cross, Robert W., et al.
Publicado: (2020)

Combination therapy with remdesivir and monoclonal antibodies protects nonhuman primates against advanced Sudan virus disease
por: Cross, Robert W., et al.
Publicado: (2022)

Combination therapy protects macaques against advanced Marburg virus disease
por: Cross, Robert W., et al.
Publicado: (2021)

Crimean-Congo hemorrhagic fever virus strains Hoti and Afghanistan cause viremia and mild clinical disease in cynomolgus monkeys
por: Cross, Robert W., et al.
Publicado: (2020)

Natural history of Sudan ebolavirus infection in rhesus and cynomolgus macaques
por: Woolsey, Courtney, et al.
Publicado: (2022)

Vesicular Stomatitis Virus-Based Vaccines Protect Nonhuman Primates against Bundibugyo ebolavirus
por: Mire, Chad E., et al.
Publicado: (2013)

Passive Immunotherapy: Assessment of Convalescent Serum Against Ebola Virus Makona Infection in Nonhuman Primates
por: Mire, Chad E., et al.
Publicado: (2016)

The Domestic Ferret (Mustela putorius furo) as a Lethal Infection Model for 3 Species of Ebolavirus
por: Cross, Robert W., et al.
Publicado: (2016)

Recombinant vesicular stomatitis virus–vectored vaccine induces long-lasting immunity against Nipah virus disease
por: Woolsey, Courtney, et al.
Publicado: (2023)

Therapy for Argentine hemorrhagic fever in nonhuman primates with a humanized monoclonal antibody
por: Zeitlin, Larry, et al.
Publicado: (2021)

Lipid nanoparticle siRNA treatment of Ebola virus Makona infected nonhuman primates
por: Thi, Emily P., et al.
Publicado: (2015)

Pathogenic Differences between Nipah Virus Bangladesh and Malaysia Strains in Primates: Implications for Antibody Therapy
por: Mire, Chad E., et al.
Publicado: (2016)

Combination treatment of mannose and GalNAc conjugated small interfering RNA protects against lethal Marburg virus infection
por: Ye, Xin, et al.
Publicado: (2023)

Establishment of an African green monkey model for COVID-19
por: Woolsey, Courtney, et al.
Publicado: (2020)

Establishment of an African green monkey model for COVID-19 and protection against reinfection
por: Woolsey, Courtney, et al.
Publicado: (2020)

Antagonism of STAT1 by Nipah virus P gene products modulates disease course but not lethal outcome in the ferret model
por: Satterfield, Benjamin A., et al.
Publicado: (2019)

Nonhuman Primates Are Protected against Marburg Virus Disease by Vaccination with a Vesicular Stomatitis Virus Vector-Based Vaccine Prepared under Conditions to Allow Advancement to Human Clinical Trials
por: Cooper, Christopher L., et al.
Publicado: (2022)

Prior vaccination with rVSV-ZEBOV does not interfere with but improves efficacy of postexposure antibody treatment
por: Cross, Robert W., et al.
Publicado: (2020)

A Cross-Reactive Humanized Monoclonal Antibody Targeting Fusion Glycoprotein Function Protects Ferrets Against Lethal Nipah Virus and Hendra Virus Infection
por: Mire, Chad E, et al.
Publicado: (2020)

Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus
por: Matassov, Demetrius, et al.
Publicado: (2015)

Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses
por: Lehrer, Axel T., et al.
Publicado: (2021)

A single dose investigational subunit vaccine for human use against Nipah virus and Hendra virus
por: Geisbert, Thomas W., et al.
Publicado: (2021)

Marburg and Ebola Hemorrhagic Fevers (Filoviruses)
por: Geisbert, Thomas W.
Publicado: (2015)

Protection Against Lethal Marburg Virus Infection Mediated by Lipid Encapsulated Small Interfering RNA
por: Ursic-Bedoya, Raul, et al.
Publicado: (2014)

Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease
por: Mire, Chad E, et al.
Publicado: (2013)

Postexposure Treatment of Marburg Virus Infection
por: Geisbert, Thomas W., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_jsf78l570vmnpechgomrgpp272